Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Eileen Francis
P&G’s health care segment advanced 4% in the third quarter to $1.84bn, but sales declined for its other business units, a trend the firm sees worldwide across consumer industries. CFO Jon Moeller unveils the firm’s “irresistible superiority” product development strategy to counter slower global consumer spending.
CVS Pharmacy is developing standards, including third-party tests, for vitamins and supplements sold in its stores. Targeted for implementation by 2019, the standards are part of a health care-focused effort in which the firm will expand its lineup of vitamins and supplements.
UK regulator tells Natural Healing Solutions to discontinue online claims its products are “programmed” with resonance patterns to read energy levels and prevent disease. In a ruling published April 19, the agency noted the company acknowledged receipt of the complaint, but did not respond.
As Amazon emerges as the leading search engine for information about consumer packaged goods products, consumer health and personal care product firms should establish a presence, even if they expect not to sell much, says BeeKeeper consultancy's Lynn Graham.
J&J says Tylenol outpaced other analgesics in the first quarter as its OTC franchise grew 1.4% on a reported basis to $1.01 bn. CFO Dominic Caruso said new consumer products will add 2 points of incremental growth to the segment in 2017.
Standard Homeopathic recalls Hyland's teething products; ACT enters children's toothpaste market; Sensodyne toothpaste recalled.